Buprenorphine: extended-release formulations "a game changer"!
- PMID: 34028813
- DOI: 10.5694/mja2.51098
Buprenorphine: extended-release formulations "a game changer"!
Keywords: Acute pain; Addiction; Drug delivery systems; Harm reduction; Opioid-related disorders; Prison.
References
-
- Hendrie D. Advocates hail “game changing” PBS listing of buprenorphine. News GP, Royal Australian College of General Practitioners, 2019. https://www1.racgp.org.au/newsgp/clinical/advocates-hail-game-changing-p... (viewed Nov 2020).
-
- Gowing L, Ali R, Dunlop A, Farrell M, Lintzeris N. National guidelines for medication-assisted treatment of opioid dependence 2014. Commonwealth of Australia, 2014. https://www.health.gov.au/sites/default/files/national-guidelines-for-me... (viewed Nov 2020).
-
- Lintzeris N, Dunlop A, Masters M. Clinical guidelines for use of depot buprenorphine (Buvidal and Sublocade) in the treatment of opioid dependence. NSW Health, 2019. https://www.health.nsw.gov.au/aod/Publications/full-depot-bupe-interim-g... (viewed Nov 2020).
-
- Frost M, Bailey GL, Lintzeris N, et al. Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder. Addiction 2019; 114: 1416-1426.
-
- Lintzeris N, Hayes V, Arunogiri S. Interim guidance for the delivery of medication assisted treatment of opioid dependence in response to COVID-19: a national response. Royal Australasian College of Physicians, 2020. https://www.racp.edu.au/docs/default-source/news-and-events/covid-19/int... (viewed Nov 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical